11. FRI0207 The input of measuring of infliximab and adalimumab levels and levels of antibodies to these drugs in the management of patients with autoimmune diseases treated with anti tnf monoclonal antibodies. (23rd January 2014) Authors: Braun-Moscovici, Y.; Ben Horin, S.; Dagan, A.; Toledano, K.; Markovits, D.; Saffouri, A.; Beshara, R.; Rozin, A.; Nahir, M. A.; Chowers, Y.; Balbir-Gurman, A. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A442 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
12. FRI0337 REAL WORLD SECUKINUMAB DRUG-SURVIVAL IN PSORIATIC ARTHRITIS. (2nd June 2020) Authors: Eviatar, T.; Zisman, D.; Lidar, M.; Reitblat, T.; Balbir-Gurman, A.; Elkayam, O. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 761 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
13. FRI0385 Long term follow-up after systemic sclerosis patients treated with intravenous cyclophosphamide pulse therapy for interstitial lung disease: a single eustar center (042) experience. (23rd January 2014) Authors: Balbir-Gurman, A.; Guralnik, L.; Yigla, M.; Hardak, E.; Solomonov, A.; Rozin, A. P.; Toledano, K.; Dagan, A.; Bishara, R.; Nahir, M. A.; Markovits, D.; Braun-Moscovici, Y. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A503 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
14. FRI0447 Worldwide expert agreement on updated eular/eustar recommendations for the treatment of systemic sclerosis. (12th June 2018) Authors: De Vries-Bouwstra, J.; Allanore, Y.; Matucci-Cerinic, M.; Balbir-Gurman, A. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 753 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
15. FRI0509 Upper Gastrointestinal Bleeding is Associated with Significantly Higher Mortality in Systemic Sclerosis Patients. (10th June 2014) Authors: Braun-Moscovici, Y.; Markovits, D.; Gralnek, I.; Toledano, K.; Beshara-Garzoz, R.; Dagan, A.; Rozin, A.; Chowers, Y.; Balbir-Gurman, A. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 571 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
16. OP0013 SINGLE CELL PROFILE OF SKIN STROMAL AND IMMUNE CELLS AND PERIPHERAL BLOOD IMMUNE CELLS OF SCLERODERMA PATIENTS TOWARDS IDENTIFICATION OF DISEASE MECHANISM, PROGNOSTIC BIOMARKERS AND POTENTIAL THERAPEUTIC TARGETS. (2nd June 2020) Authors: Gur, C.; Balbir-Gurman, A.; Peleg, H.; Aamar, S.; Kharouf, F.; Braun-Moscovici, Y.; Wang, S. Y.; Amit, I. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 9 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
17. OP0030 Associated Factors with Mortality and Derivation of A Simple 5-Factors To Predict Mortality in Ssc-Patients in The Eustar Cohort. (15th July 2016) Authors: Elhai, M.; Meune, C.; Hachulla, E.; Balbir-Gurman, A.; Riemekasten, G.; Airò, P.; Carreira, P.; Allanore, Y. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 64 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
18. OP0031 Risk Factors for Malignancies Synchronous To The Onset of Systemic Sclerosis in Patients Positive for Anti- RNA Polymerase III Antibodies: A Eustar Multicentre Study. (15th July 2016) Authors: Lazzaroni, M.G.; Cavazzana, I.; Colombo, E.; Distler, O.; Dobrota, R.; Hernandez, J.; Hesselstrand, R.; Czirjak, L.; Varju, C.; Nagy, G.; Smith, V.; Caramaschi, P.; Riccieri, V.; Hachulla, E.; Romanowska-Prochnicka, K.; Balbir-Gurman, A.; Chatelus, E.; Araùjo, A.C.; Allanore, Y.; Airò, P. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 64 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
19. OP0055 Anti-RNA Polymerase III Antibodies in Patients with Systemic Sclerosis: A Eustar Multicenter Collaborative Study. (9th June 2015) Authors: Lazzaroni, M.G.; Colombo, E.; Cavazzana, I.; Distler, O.; Hesselstrand, R.; Smith, V.; Caramaschi, P.; Hachulla, E.; Balbir-Gurman, A.; Romanowska-Pròchnicka, K.; Riccieri, V.; Allanore, Y.; Airo', P. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 88 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
20. OP0207 The outcomes of limited cutaneous systemic sclerosis patients: a eustar database study. (12th June 2018) Authors: Frantz, C.; Huscher, D.; Hachulla, E.; Balbir-Gurman, A.; Riemekasten, G.; Siegert, E.; Airo, P.; Joven, B.; Vettori, S.; Cozzi, F.; Ullman, S.; Czirjak, L.; Allanore, Y. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 152 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗